Abstract:ABSTRACT Despite effective antiretroviral therapy reducing HIV-1 viral loads to undetectable levels, the presence of latently infected CD4 + T cells poses a major barrier to HIV-1 cure. N 6 -methyladenosine (m 6 A) modification of viral and cellular RNA has a functional role in regulating HIV-1 infection. m 6 A modification of HIV-1 RNA can affect its stability, translation, and splicing in cells and suppresses type-I interferon induction in macrophages. However, the function of m 6 A modification in regulating HIV-1 latency reactivation remains unknown. We used the Jurkat T cell line-derived HIV-1 latency model (J-Lat cells) to investigate changes in m 6 A levels of cellular RNA in response to latency reversal. We observed a significant increase in m 6 A levels of total cellular RNA upon reactivation of latent HIV-1 in J-Lat cells. This increase in m 6 A levels was transient and returned to steady-state levels despite continued high levels of viral gene expression in reactivated cells compared to control cells. Upregulation of m 6 A levels occurred without significant changes in the protein expression of m 6 A writers or erasers that add or remove m 6 A, respectively. Knockdown of m 6 A writers in J-Lat cells significantly reduced HIV-1 reactivation. Treatment with an m 6 A writer inhibitor reduced cellular RNA m 6 A levels, along with a reduction in HIV-1 reactivation. Furthermore, using m 6 A-specific sequencing, we identified cellular RNAs that are differentially m 6 A-modified during HIV-1 reactivation in J-Lat cells. Knockdown of identified m 6 A-modified RNA validates these results with an established primary CD4 + T cell model of HIV-1 latency. These results show the importance of m 6 A RNA modification in HIV-1 latency reversal. IMPORTANCE RNA m 6 A modification is important for regulating gene expression and innate immune responses to HIV-1 infection. However, the functional significance of m 6 A modification during HIV-1 latency reactivation is unknown. To address this important question, in this study, we used established cellular models of HIV-1 latency, m 6 A-specific sequencing at single-base resolution, and functional assays. We demonstrate that HIV-1 latency reversal leads to increased levels of cellular m 6 A modification, correlates with cellular m 6 A levels, and is dependent on the catalytic activity of the m 6 A methyltransferase enzyme. We also identified cellular genes that are differentially m 6 A-modified during HIV-1 reactivation, as well as the sites of m 6 A within HIV-1 RNA. Our novel findings point toward a significant role for m 6 A modification in HIV-1 latency reversal.

Transcriptomic study reveals alteration in the expression of long non-coding RNAs (lncRNAs) during reversal of HIV-1 latency in monocytic cell line

Identify Potential Regulators in Hiv-1 Latency by Joint Microrna and Mrna Analysis

Research progress on HIV latency-reversing agents and its mechanism

Identification of CD98 As a Novel Biomarker for HIV-1 Permissiveness and Latent Infection

Integrated Single-cell Multiomic Analysis of HIV Latency Reversal Reveals Novel Regulators of Viral Reactivation

Targeting noncoding RNAs to reactivate or eliminate latent HIV reservoirs

MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV

High-throughput Sequencing Identifies HIV-1-replication- and Latency-Related Mirnas in CD4+ T Cell Lines.

Role of long noncoding RNA in regulating HIV infection—a comprehensive review

NSC95397 is a Novel HIV-1 Latency Reversing Agent

Long non-coding RNA uc002yug.2 activates HIV-1 latency through regulating mRNA level of various RUNX1 isoforms and increasing Tat expression.

Effective and targeted latency reversal in CD4+ T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection

The cell biology of HIV-1 latency and rebound

Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression

Differential expression of lncRNAs during the HIV replication cycle: an underestimated layer in the HIV-host interplay

Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency

The lncRNA NRON modulates HIV-1 replication in a NFAT-dependent manner and is differentially regulated by early and late viral proteins

Targeting Viral Transcription for HIV Cure Strategies

Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs

Epitranscriptomic m6A modifications during reactivation of HIV-1 latency in CD4+ T cells

Screening for gene expression fluctuations reveals latency-promoting agents of HIV